Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe
Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe
RELEASE DATE
28-Dec-2006
28-Dec-2006
REGION
Europe
Europe
Deliverable Type
Market Research
Market Research
Research Code: B796-01-00-00-00
SKU: HC01173-EU-MR_05270
₹413,173.53
In stock
SKU
HC01173-EU-MR_05270
Description
This research highlights the various issues affecting the pricing and reimbursement environment for generics in Europe. It includes an overview of the generics market, key trends, country-wise market trends, list of market participants, strategic suggestions and decision support databases.
Table of Contents
Executive Summary
- Executive Summary
Important Terms
- Definitions
Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , Research Methodology
Methodology Of Research
- The "12 Step" Market Engineering Research Methodology and Process
Overview
- Market Analysis
- Scope and Objectives
- Pricing and Reimbursement
- The Biosimilars Opportunity
Pharmaceutical Cost-containment Measures
- Reference Pricing
- Parallel Trade
- Generic Substitution
- Patient Co-payments and Reimbursement
Political/Legal/Regulatory Issues
- Impact of EU Accession
- The Roche/Bolar Provision
- Data Exclusivity and Marketing Authorisation Applications
Group I
Group II
- Denmark
- Germany
- The Netherlands
- The United Kingdom
Group III
- Austria
- Belgium
- France
- Italy
- Portugal
- Spain
Market Players
Recommendations to Market Participants
Popular Topics
This research highlights the various issues affecting the pricing and reimbursement environment for generics in Europe. It includes an overview of the generics market, key trends, country-wise market trends, list of market participants, strategic suggestions and decision support databases.
Deliverable Type | Market Research |
---|---|
No Index | Yes |
Podcast | No |
Industries | Healthcare |
WIP Number | B796-01-00-00-00 |
Is Prebook | No |